Interpretation of Results of Routine and Special Coagulation Tests

Gene Gulati is a nationally and internationally known clinical laboratory hematologist. Dr Gulati's professional career spans nearly four decades, directing hematology and coagulation laboratories and teaching hematology to hematopathology fellows, pathology residents, medical students, and laboratory professionals among two teaching institutions (Muhlenberg Regional Medical Center affiliated with Robert Wood Johnson Medical School of Rutgers University in New Jersey and Jefferson Medical College (now Sidney Kimmel Medical College) and Hospital of Thomas Jefferson University in Philadelphia, PA). His accomplishments include five books, many articles in peer-reviewed medical journals, and multiple presentations at regional, national, and international conferences organized by professional societies. He has been honored with Distinguished Emeritus Membership by American Society of Hematology and Emeritus Membership by American Society for Clinical Pathology. Dorothy Adcock is an eminent specialist in the field of pathology, with expertise in clinical pathology, particularly hemostasis, in national and international settings for over 30 years. Dr. Adcock has chaired the Hematology and Pathology Device Panel for the FDA, served on the Hematopathology Test Development Committee of the ABP, is the past-president of North American Specialized Coagulation Laboratory Association, and received the 2019 ASCP Mastership Award, which recognizes individuals who have significantly contributed to the field of pathology/laboratory medicine. She has drafted several hemostasis guideline documents for the International Council for Standardization in Hematology and has authored over 130 peer-reviewed hemostasis-related articles and book chapters. Ruben Rhoades is a classical hematologist with a clinical and research interest in disorders of thrombosis and hemostasis. He directs the Cardeza Foundation Hemophilia and Thrombosis Center at Thomas Jefferson University, caring for patients with inherited and acquired bleeding disorders and thrombophilias. He conducts outcomes research in these patients and studies laboratory testing in coagulopathies, and is a principal investigator on studies of novel therapies, including in heparin-induced thrombocytopenia and gene therapy in hemophilia A.